Skip to Content

CL 403 (Nevirapine Extended-Release 400 mg)

Pill with imprint CL 403 is Yellow, Capsule-shape and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Cipla USA Inc..

Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 403

Nevirapine extended-release 400 mg CL 403

Nevirapine Extended-Release

Imprint
CL 403
Strength
400 mg
Color
Yellow
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
NNRTIs
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0403
Inactive Ingredients
lactose monohydrate, hypromelloses, ferric oxide yellow, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "CL 403"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.